May Health has raised $11.7 million, to complete its pivotal U.S. IDE trial and support European launch planning for the Anavi System, a one-time office-based treatment designed to restore ovulation in women with PCOS-related infertility.
"May Health is addressing a critical gap in modern infertility care, [...] the company is reshaping the treatment paradigm for millions of women worldwide. We are proud to support a world-class team advancing meaningful progress in women’s healthcare.” — Colby Holtshouse, President & Chief Executive Officer, May Health
Malama Health has raised $9.2 million to expand its tech-enabled, doula-led maternal care model nationwide. The company partners with clinics, health systems and Medicaid plans to deliver community-based support, remote monitoring and care navigation for pregnant and postpartum women.
"Building Malama has meant building an infrastructure that the healthcare system did not already have. [...] Trust with communities that have every reason to distrust the healthcare system." — Mika Eddy, Co-Founder & CEO, Malama Health
The University of Auckland is supporting a NZ$5.1 million programme funded by the Matariki Fund to help eliminate cervical cancer across the Pacific, where incidence rates are reported to be up to nine times higher than in Australasia
"This investment allows Pacific countries to work together - sharing expertise, strengthening systems, and supporting women leaders - to achieve elimination,"
Costco members can now access fertility consultations and coordinated care through a new partnership with Sesame and IVI RMA, including discounted medications and specialist support.
“This partnership empowers people to take control of their reproductive health without barriers, stigma, or waiting. By connecting patients directly with care coordinators and world-class specialists, we’re making family planning accessible and delivering measurably better outcomes through coordinated, continuous care.” — David Goldhill, CEO & Founder, Sesame
🔗 https://rmanetwork.com/blog/costco-sesame-ivi-rma-partner-fertility-care/
A new non-hormonal daily menopause pill has been approved for NHS use, offering an alternative for women experiencing debilitating hot flushes and night sweats who cannot or do not want to use hormone replacement therapy. Around 500,000 women are expected to be eligible.
"For those who are unable to take HRT for varying reasons, options have historically been limited, and we have heard clearly from patients how difficult that can be. This decision will give much-needed relief to those for whom HRT is unsuitable." — Helen Knight, Director of Medicines Evaluation, NICE
🔗 https://www.bbc.co.uk/news/articles/cn0znqkqkdro
Care Ventures Group has made a strategic investment in REN Health, positioning the company for its next phase as an AI-enabled women’s wellness platform focused on hormonal regulation, menstrual support and postpartum recovery.
🔗 https://vir.com.vn/cvg-invests-in-ren-wellness-to-expand-womens-health-portfolio-148163.html
The funding will support initiatives related to abortion access, fertility services, endometriosis awareness, midwifery support and menopause education, with groups including the Society of Obstetricians and Gynaecologists of Canada, Abortion Care Canada and Fertility Matters Canada among the recipients.
🔗 https://www.cbc.ca/news/politics/sexual-reproductive-health-funding-9.7117932
